Skip header and navigation

6 records – page 1 of 1.

Consumption of asthma medication after RS-virus epidemic--a population based survey.

https://arctichealth.org/en/permalink/ahliterature78560
Source
Pediatr Allergy Immunol. 2007 Mar;18(2):105-9
Publication Type
Article
Date
Mar-2007
Author
Dunder Teija
Juntti Hanna
Renko Marjo
Kokkonen Jorma
Waris Matti
Uhari Matti
Author Affiliation
Department of Pediatrics, University of Oulu, Oulu, Finland. teija.dunder@oulu.fi
Source
Pediatr Allergy Immunol. 2007 Mar;18(2):105-9
Date
Mar-2007
Language
English
Publication Type
Article
Keywords
Adolescent
Anti-Asthmatic Agents - therapeutic use
Asthma - drug therapy - etiology
Child
Child, Preschool
Disease Outbreaks
Humans
Infant
Infant, Newborn
Respiratory Syncytial Virus Infections - complications - epidemiology
Respiratory Syncytial Virus, Human
Abstract
It has been suggested that a respiratory syncytial virus (RSV) infection in infancy increases the likelihood of development of asthma in childhood. The RSV epidemics have a special 2-yr pattern in Finland and this allows the evaluation of the association of RSV and asthma by epidemiological means. We evaluated whether being 0-6 months of age during an RSV epidemic has an impact on the use of asthma medication later in the childhood. The consumption of asthma medication at the age of 3-16 yr and the number of those entitled to special reimbursement for asthma medication were identified for a total of 637,922 children. These subjects were grouped in cohorts according to whether they had been aged 0-6 months (exposed) or not (unexposed) during an RSV epidemic. The means of the proportions taking asthma medication and of those receiving reimbursement were calculated for each cohort. The means of the proportions in the unexposed vs. exposed cohorts were 20.5% vs. 20.3% for consumption and 4.8% vs. 4.9% for reimbursement. These differences were insignificant. In conclusion exposure to a RSV epidemic in infancy does not increase the consumption of asthma medicines at the population level.
PubMed ID
17338782 View in PubMed
Less detail

Cytokine responses in cord blood predict the severity of later respiratory syncytial virus infection.

https://arctichealth.org/en/permalink/ahliterature88876
Source
J Allergy Clin Immunol. 2009 Jul;124(1):52-58.e1-2
Publication Type
Article
Date
Jul-2009
Author
Juntti Hanna
Osterlund Pamela
Kokkonen Jorma
Dunder Teija
Renko Marjo
Pokka Tytti
Julkunen Ilkka
Uhari Matti
Author Affiliation
Department of Paediatrics, University of Oulu, PO Box 5000, University of Oulu, Oulu FI-90014, Finland. hanna.juntti@oulu.fi
Source
J Allergy Clin Immunol. 2009 Jul;124(1):52-58.e1-2
Date
Jul-2009
Language
English
Publication Type
Article
Keywords
Child
Cytokines - metabolism
Fetal Blood - immunology
Humans
Immunity, Innate
Infant
Infant, Newborn
Leukocytes, Mononuclear - immunology
Prospective Studies
Reference Standards
Respiratory Syncytial Virus Infections - immunology
Risk factors
Severity of Illness Index
Abstract
BACKGROUND: It has been claimed that an early respiratory syncytial virus (RSV) infection can induce asthma and recurrent wheezing. OBJECTIVE: We addressed the question of whether infants contracting an early RSV infection differ from healthy children in their cytokine production at birth. METHODS: In a prospective cohort study cord blood samples were collected from 1084 newborns during autumn 2001. Of 47 of these newborns with subsequent virologically confirmed RSV infection before 6 months of age, 24 had enough cells for stimulation in cord blood samples (14 of those were hospitalized). Twenty-eight children had other respiratory virus infections (16 with enough cells), and samples from 48 healthy children of the 1084 total served as control specimens. Stimulated cytokine production of mononuclear cells was measured. The responses in the groups were evaluated by means of factor analysis. RESULTS: The infants hospitalized for RSV infection had higher LPS-stimulated combined IL-6 and IL-8 responses than the infants treated as outpatients (P = .005) or the healthy control subjects (P = .02). The hospitalized patients with RSV showed lower IL-1beta, IL-2, IL-4, IL-5, and IL-10 responses than those treated as outpatients (P = .02). High IL-6 and IL-8 responsiveness predicted a severe RSV infection (odds ratio, 2.20; 95% CI, 1.17-4.14; P = .01). The unstimulated cytokine responses at birth did not differ between the patients and healthy control subjects. CONCLUSION: The results suggest that natural differences in innate immunity predispose children to severe RSV infection rather than the infection modifying immune responses in childhood.
PubMed ID
19482350 View in PubMed
Less detail

Infections in child day care centers and later development of asthma, allergic rhinitis, and atopic dermatitis: prospective follow-up survey 12 years after controlled randomized hygiene intervention.

https://arctichealth.org/en/permalink/ahliterature84241
Source
Arch Pediatr Adolesc Med. 2007 Oct;161(10):972-7
Publication Type
Article
Date
Oct-2007
Author
Dunder Teija
Tapiainen Terhi
Pokka Tytti
Uhari Matti
Author Affiliation
Department of Pediatrics, University of Oulu, PO Box 5000, FIN-90014 Oulu, Finland. teija.dunder@oulu.fi
Source
Arch Pediatr Adolesc Med. 2007 Oct;161(10):972-7
Date
Oct-2007
Language
English
Publication Type
Article
Abstract
OBJECTIVE: To evaluate the effect of successful prevention of common infections in child day care centers on the later development of allergic diseases. DESIGN: Prospective follow-up survey with a questionnaire administered 12 years after a controlled randomized hygiene intervention. SETTING: Twenty municipal child day care centers in Oulu, Finland. PARTICIPANTS: A questionnaire was sent to 1354 prior participants (98%) in the intervention trial. The response rate was 68% (928 of 1354 participants). MAIN INTERVENTION: Hygiene intervention from March 1, 1991, to May 31, 1992. MAIN OUTCOME MEASURES: The number of respondents who had a diagnosis of asthma, allergic rhinitis, and/or atopic dermatitis made by a physician, and the number of those who reported symptoms of atopic diseases. RESULTS: Asthma was diagnosed by a physician in 48 of the 481 respondents (10%) from the intervention child day care centers, with markedly fewer infections, and in 46 of the 447 controls (10%) (relative risk, 1.0; 95% confidence interval, 0.7-1.4). Similarly, no differences were found in the numbers of children who had a diagnosis of other atopic diseases or who had reported such symptoms. CONCLUSION: The prevention of common respiratory tract and enteric infections during early childhood does not change later allergic morbidity.
PubMed ID
17909141 View in PubMed
Less detail

Risk factors for croup in children with recurrent respiratory infections: a case-control study.

https://arctichealth.org/en/permalink/ahliterature90339
Source
Paediatr Perinat Epidemiol. 2009 Mar;23(2):153-9
Publication Type
Article
Date
Mar-2009
Author
Pruikkonen Hannele
Dunder Teija
Renko Marjo
Pokka Tytti
Uhari Matti
Author Affiliation
Department of Pediatrics, University of Oulu, Oulu, Finland.
Source
Paediatr Perinat Epidemiol. 2009 Mar;23(2):153-9
Date
Mar-2009
Language
English
Publication Type
Article
Keywords
Animals
Animals, Domestic
Cats
Child
Croup - etiology
Epidemiologic Methods
Female
Genetic Predisposition to Disease
Humans
Male
Recurrence
Respiratory Tract Infections - complications
Socioeconomic Factors
Tobacco Smoke Pollution - adverse effects
Abstract
Croup accounts for approximately 15% of all lower respiratory disease in children, but little is known about risk factors or its recurrence rate. The aim of this study was to determine the risk factors for croup and recurrent croup and to find out whether it is possible to predict the course of the disease. We considered croup patients who visited the Paediatric Department of Oulu University Hospital as primary health care patients at night during 1996-2000. For most analyses we used sex- and age-matched control patients who had had other respiratory infection but for environmental factors we used population controls. We performed conditional logistic regression analysis on data applying to 182 pairs of patients and controls. The recurrence rate was high, as 61% of the croup patients had had at least three episodes. Family history of croup was the most significant risk factor for both croup itself and recurrent croup. In multivariable analysis the odds ratio (OR) for the parents having a history of croup was 3.2 (95% CI 1.5, 7.1, P
PubMed ID
19159401 View in PubMed
Less detail

Use of inhaled corticosteroids decreases hospital admissions for asthma in young children.

https://arctichealth.org/en/permalink/ahliterature94449
Source
World J Pediatr. 2009 Aug;5(3):177-81
Publication Type
Article
Date
Aug-2009
Author
Korhonen Kaj
Dunder Teija
Klaukka Timo
Reijonen Tiina M
Korppi Matti
Author Affiliation
Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.
Source
World J Pediatr. 2009 Aug;5(3):177-81
Date
Aug-2009
Language
English
Publication Type
Article
Abstract
BACKGROUND: An active use of inhaled corticosteroids for asthma has been associated with less asthma exacerbations and hospital admissions in children aged more than 2 years. The present study aimed to investigate hospital admission rates in young children from two populations in relation to the age-specific use of maintenance medication for asthma. METHODS: Annual data on children aged less than 24 months treated for asthma, including data on the use of maintenance medication based on the purchases of prescribed medications, and annual numbers of admissions to hospital and proportions of readmissions, were collected from 1995 to 1999 in two provinces of Finland. The inclusion criteria, three or more doctor-diagnosed wheezing episodes, were individually checked by the authors in each case. The mean number of children aged less than 24 months during the years of the study was 5490 in Kuopio and 9914 in Oulu area. RESULTS: In the Kuopio area, during the years of the study, 16.5/1000 children aged less than 24 months were on maintenance medication for asthma, and 90% of them were receiving inhaled corticosteroids. In the Oulu area, the respective figures were 13.5/1000 (P
PubMed ID
19693460 View in PubMed
Less detail

6 records – page 1 of 1.